NSC |
Compound |
Enrichment |
Correlation |
NSC 740357 |
Null |
0.0237269271456697 |
0.019803818 |
NSC 743433 |
8-(4-{4-[6-(4-piperazinoquinazoline)-7-methoxy-2,3,5,11-atetrahydra-1H-benzo[e]pyrrolo[1,2-c][1,4]diazepin-5-one |
0.0237269271456697 |
0.37844871 |
NSC 743695 |
Null |
0.0237269271456697 |
0.27021612 |
NSC 744688 |
Null |
0.0237269271456697 |
0.50918334 |
NSC 750050 |
Null |
0.0237269271456697 |
0.1595266 |
NSC 753377 |
3-[2-(1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine |
0.0237269271456697 |
0.28397678 |
NSC 753598 |
Null |
0.0237269271456697 |
0.079537261 |
NSC 761822 |
(Z)-3-((1-(4-fluorophenyl)-9H-pyrido[3,4-b]indol-3-yl)methylene)-5-methoxyindolin-2-one |
0.0237269271456697 |
0.12171053 |
NSC 762901 |
trans-4-{4-[3-(4-chloro-3-trifluoromethyl-phenyl)-ureido]-cyclohexyloxy}-pyridine-2-carboxylic acid methylamide |
0.0237269271456697 |
0.45106746 |
NSC 762908 |
2-(4-(methylsulfonyl)phenyl)-6-p-tolyl-4,5-dihydropyridazin-3(2H)-one |
0.0237269271456697 |
0.21889203 |